Neurobiological disorders have diverse manifestations and symptomology. Neurodegenerative disorders, such as Alzheimer's disease, manifest late in life and are characterized by, among other symptoms, progressive loss of synaptic markers. Developmental disorders, such as autism spectrum, appear in childhood. Neuropsychiatric and affective disorders, such as schizophrenia and major depressive disorder, respectively, have broad ranges of age of onset and symptoms. However, all share uncertain etiologies, with opaque relationships between genes and environment. We propose a 'Latent Early-life Associated Regulation' (LEARn) model, positing latent changes in expression of specific genes initially primed at the developmental stage of life. In this model, environmental agents epigenetically disturb gene regulation in a long-term manner, beginning at early developmental stages, but these perturbations might not have pathological results until significantly later in life. The LEARn model operates through the regulatory region (promoter) of the gene, specifically through changes in methylation and oxidation status within the promoter of specific genes. The LEARn model combines genetic and environmental risk factors in an epigenetic pathway to explain the etiology of the most common, that is, sporadic, forms of neurobiological disorders.
LEARn model
Neurobiological disorders have diverse manifestations and symptomology. Neurodegenerative disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD), usually appear late in life and are characterized by progressive loss of synaptic markers and cholinergic neurons in AD, and nigrostriatal projection neurons in PD, both eventually resulting in dementia. [1] [2] [3] Developmental disorders, such as autism spectrum, usually manifest in childhood and are typified by symptoms such as difficulty in pragmatic communication and social interaction, repetitive and stereotyped movements, and perseveration on a limited range of interests. 4 Neuropsychiatric disorders, such as bipolar disorder and schizophrenia, tend to appear in adolescence and early adulthood. Bipolar disorder is associated with a cycling of depressive and manic/hypomanic symptoms. 5 Schizophrenia has a complex of symptoms that includes lack of affect, social withdrawal, hallucinations and disordered thinking. Other disorders include major depressive disorder (MDD) and anxiety disorders, which have a broad range of age of onset and manifest as a severe and pervasive emotional state together with behavioral and somatic symptoms.
All of these disorders share genetic risk factors that have incomplete penetrance. It is possible to have a 'pathogenic' allele without developing the associated disorder. The popular current model is a polygenic/ multifactorial model that renders no single contributory factor either necessary or sufficient. It is, instead, the interaction of multiple agents that is presumed to lead to a disorder, with some potential for environmental input.
A useful categorization of disease progression divides disorders and diseases into a few general models. An acute disorder begins shortly after a trigger event has occurred ( Figure 1a ) and progresses, ultimately (presuming that it is not fatal) being selflimiting, with restoration of function at end of the disease episode. Many infectious diseases, such as rubella, fall into this category. A chronic (Figure 1b ) disorder likewise clinically presents after a trigger has occurred. However, the chronic disorder remains active for an extended period, potentially throughout an organism's lifespan. This model would likely fit several classes of disorder, such as emphysema.
Latent (Figures 1c-d ) disorders do not quickly manifest symptoms after an initial etiological trigger or 'hit' occurs. Within latent disorders, two subtypes can be characterized. Long prodromal phase disorders ( Figure 1c ) are characterized by a 'one-hit' etiology. A single triggering event is sufficient to induce the disease state, which simply takes an appreciable amount of time to 'build up' to a clinical level, this latency could be manifested as recurrent sporadic symptomatic periods, such as with herpes simplex virus infection, or a latent period followed by an extended symptomatic period, as with HIV infection. 'Two-hit' latency ( Figure 1d ) is an etiology that begins with an initial event or condition that, in and of itself, is insufficient to produce a disease state. The first hit could be exposure to environmental toxins, heavy metals, nutritional deficiency, stress or even inherited genetic or epigenetic substrate. Later in life, a second hit would occur that, in those organisms that had suffered the first hit, would lead to disease. However, in organisms that were not subject to the first hit, no disease would occur. This model makes the greatest allowance for 'sporadic' appearance of a disorder, especially if, instead of being 'two hit', it is actually 'many' or 'n hit', where 'n' can be any number of individual risk factors, each with the potential to instill or activate a latent alteration. The most wellcharacterized 'n-hit' disorders would be cancers.
We propose that many neurobiological disorders, regardless of their symptomatic variety, share a fundamentally similar mechanistic etiology: 'Latent Early-life Associated Regulation' or 'LEARn', based on the somatic epitype. [6] [7] [8] Under LEARn, early life stressors modify potential expression levels of disorder-associated genes in a latent manner. Latent changes in these genes are maintained by epigenetic mechanisms such as DNA methylation, DNA oxidation and chromatin reorganization. LEARn-modified genes may require multiple 'hits' to express at pathological levels. This is similar to the 'two-hit' model of oncology. 9 Recent work on primates and rodents has led to the determination that early life exposure to external stress agents, such as lead (Pb), may induce a short-term upregulation of diseaseassociated genes, followed by a long latency period of 'normal' levels of gene expression, but this period Figure 1 Models of disease progression. Disease progression usually follows one of the four models. (a) Acute disease. An etiological agent or condition 'single hit' (including a genetic mutation) takes immediate or near term to exposure effect, resulting in loss of function that progresses to disease symptoms, which eventually recede. (b) Immediate-trigger chronic disease. An etiological agent or condition takes immediate or near term to exposure effect, resulting in loss of function that progresses to disease symptoms, which continue throughout life, or at least for some considerable time. (c) One-hit latent disease. An etiological agent or condition imposes immediate or near-term effect, but the effects are subclinical for an extended period. Over time, loss of function increases to a pathological level without any further 'hits' to the organism. (d) Two-hit latent disease. An etiological agent or condition affects an organism but does not result in a diseased state. This alteration is maintained through the organism's lifespan without readily visible effect unless a second hit intrudes. This interacts with the 'embedded effect' of the first to produce a disease state.
ends when disease-associated gene expression levels increase later in life (Figures 2a and b) . 10, 11 In addition, oxidative DNA damage, as measured by the presence of Oxo 8 dG, remains low early in life but at some point is increased, potentially due to suppression of repair enzyme expression. This oxidation would contribute to overall epigenetic changes and influence expression of 'pathogenic genes', resulting in increase in expression levels of such genes (Figure 2b ).
The LEARn model also postulates that in the case of disorders with distinctive ages of onset the final 'hit' may be normal large-scale changes in gene expression that occur at various stages of development, such as puberty (both onset and end) or onset of senescence. However, for disorders that do not have such a characteristic age of onset, 'non-shared' environmental influences would act as a temporally proximal trigger.
In addition, LEARn posits two categories of target genes, 'LEARned' and 'unLEARned', which are structurally distinct from each other. These structural differences are in the primary DNA sequences of the gene, specifically in densities of CpG and GG dinucleotides. LEARned, or responder, genes follow the LEARn pathway while unLEARned, or nonresponder, genes do not.
In the LEARn model, environmental agents (for example, heavy metals), agrichemicals (for example, pesticides-containing water), intrinsic factors (for example, 'pathogenic' alleles or inflammatory cytokines), dietary factors (for example, folate and cholesterol) and lifestyle habits (for example, physical exercise) act at early developmental stages to alter gene regulation in a long-term manner. These disturbances would not produce disease states on their own, 7, 10 and even then only after a latent period that may last up to several years ( Figure 3 ). Similar hypotheses were developed in the 1980s by Barker et al. 12 However, Barker's model is based on low birth weight and rapid childhood weight gain, without identifying a molecular mechanism. Our LEARn model is based on the regulatory structure common to eukaryotic genes and on epigenetic processes operating at specific sites within the promoter 10,11 (a) Susceptible genes undergo an early life exposure to a stress such as heavy metals, inadequate maternal care or nutritional deficit. This may result in an acute increase in expression levels that quickly returns to 'normal' expression. Later in life, an additional trigger may affect genes. Those organisms that have been previously subjected to the initial trigger experience a significant increase in expression levels of disease-associated genes, whereas genes in organisms not primed in such a manner do not. (b) Schematic representation of pathologically associated genes and DNA oxidation damage in relationship to LEARn. Shortly after exposure to initial trigger, genes associated with a disorder would experience alterations such as an increase in expression level, whereas overall DNA oxidation would not be perturbed early in life. Later in life, DNA oxidation would be perturbed, which would lead to activation of the promoters of disease-associated genes, leading to active disease. For illustration, AD-related genes and products are shown as how the LEARn pathway could explain AD pathogenesis.
(regulatory) region of specific genes. The LEARn model is consistent with the Barker model of fetal origins of adult disease. It is also consistent with the more recently detailed 'DOHaD' (developmental origins of health and disease) model. 13 LEARn, however, enlarges on both of these models by providing specific biochemical and molecular pathways that can be directly tested. LEARn introduces an intermediate step between genotype and phenotype, specifically the 'somatic epitype', which is an epigenotype acquired after birth. 8 Evidence for the somatic epitype includes changes in DNA methylation induced by maternal behavior.
14 LEARn explains maintained latency as epigenetic modification of gene regulatory sequences. Although LEARn is similar to the proposals of Szyf, 15 there are major differences. LEARn is not a toxicological model. We expand upon these other models by positing structurally 'LEARned' and 'unLEARned' gene regulatory sequences and by including DNA oxidation in addition to methylation as a latent epigenetic marker. LEARn addresses the 'black box' of the etiology of sporadic disorders. It builds upon our findings that, in addition to latency and epigenetics, expression levels of specific transcription factors, such as specificity protein 1 (SP1), and changes in primary DNA sequence oxidation levels interacting with neighboring methylation sites, make up testable physical sites of the model's activity. In addition, we have determined that expression of critical transcription factors, such as SP1, parallels expression levels of disease-associated genes in model disorders, such as Alzheimer's b-amyloid precursor protein (APP). 16 
Neurodegenerative disorders
Degenerative neurobiological disorders include diseases such as PD and AD. These diseases have a significant genetic component. Longitudinal studies have shown disease concordance for PD of 77% in monozygotic twins and 22% in dizygotic twins; however, cross-sectional twin studies contradict these findings. 17, 18 Twin studies of AD indicate concordance of 75-80% in monozygotic twins and 26-46% in dizygotic twins. 19, 20 Nevertheless, the majority of AD and PD cases cannot be explained by autosomal inheritance, which account for less than 1% 21 of PD and 5% 2 of AD. Genes associated with PD include a-synuclein (SNCA), 22 catechol-O-methyltransferase (COMT) 23 and microtubule-associated protein-t (MAPT). 24, 25 Genes associated with AD include APP, 26 apolipoprotein E (APOE), 27 b-amyloid cleaving enzyme 1 (BACE1), 28 MAPT, 25, 29 and the presenilins 1 and 2 (PSEN1, PSEN2). 30 However, many more genes have been reported to be associated with these disorders (Supplementary Table 1) .
Environmental factors, such as nutritional imbalance, stress and exposure to risk agents such as heavy metals (for AD) 31 or pesticides (for PD) 32 are implicated but also fail to completely explain disease incidence. Presentation of disease symptoms usually occurs in the absence of an immediate trigger, strongly suggesting a long latent period. Finally, there is growing evidence that many of these diseases may be 'interlocking'; risk factors that contribute to one of these diseases potentially contribute to other neurodegenerative disorders, such as the involvement of SNCA, Ab and MAPT in both AD and PD. 33, 34 Neurodevelopmental disorders Neurodevelopmental conditions have a highly sporadic nature characterized by genetic and environmental risk factors. These include schizophrenia and autism, both of which have distinctive ages of onset. 35, 36 Genetic risk factors such as neuregulin-1 (NRG1) 37 for schizophrenia and reelin (RELN) or fragile-X mental retardation protein (FMR1) 38 for autism, are among the many that have been implicated (Supplementary Table 1 ). However, as is the case for neurodegenerative disorders, genetic risk factors are not certain indicators. Environmental risk factors for schizophrenia include complications at birth, 39, 40 childhood viral infections of the central nervous system 41 and maternal exposure to severe adverse life effects such as death of a close relative during pregnancy. 42 Autism has been linked to greater paternal age 43 and prenatal stress, 44 among other factors.
Other neuropsychiatric disorders
Incomplete penetrance extends to other conditions, including bipolar disorder, MDD and obsessivecompulsive disorder (OCD). These disorders manifest at any age or life stage. Genetic associations for these disorders (Supplementary Table 1 ), include brainderived neurotrophic factor (BDNF) 45 for bipolar disorder and the serotonin transporter protein (SLC6A4) for MDD 46 and OCD. 47 These associations have also been found to be 'incomplete'. Likewise, strong environmental components have been recognized in the etiology of OCD, bipolar disorder and MDD, such as advanced paternal age and bipolar disorder, parental bonding variation and OCD, and childhood parental loss and MDD.
48-51
Alzheimer's disease as a model for idiopathic neuropsychiatric disorders
From an epidemiological standpoint, AD could be considered sufficient to model many aspects of neurodegenerative, neurodevelopmental and neuropsychiatric disorders. AD manifests late in adult life, and it is not clearly understood when the disease begins its progression, nor how long this process takes. Large longitudinal studies have suggested that significant risk for developing AD is established in early adulthood. 52 Although this has led some researchers to conclude that AD must be a genetic disorder, such a conclusion dismisses well-established environmental risk factors such as inflammation, 53 cholesterol/diet, 54 head injury 55 and reduced midlife physical activity. 56 Even taking into account the very well established genetic risk factor of the APOEe4 genotype, 27 the majority of AD cases are idiopathic. A unifying hypothesis for the etiology of AD must take into account both its neuropathological features and multiple environmental factors associated with AD.
Biological mechanism of the LEARn model
Oxidation of DNA often occurs as oxidation of D-guanosine to oxo 8 D-guanosine. The 5 0 'G' of a 'GG' dinucleotide is a hot spot of such oxidation. 57 This interferes with the DNA-binding capacity of methyl CpG-binding protein (MeCP) to a methylated cytosine, 58 producing an 'effective demethylation' due to oxidative damage of DNA.
Methylation in mammalian DNA usually is the addition of a methyl group to cytosine residues at CpG dinucleotides. 58 This reaction is catalyzed by DNA methyltransferase (DNMT) enzymes. 59 Hypomethylation in the promoter region leads to elevated gene expression, whereas hypermethylation results in decreased gene expression. Environmental stressors, including exposure to metals and dietary factors, may interfere with the methylation of CpG clusters, thus altering affinity with potential transcription factors proteins, such as MeCP and SP1. The activity of DNMT is reduced by heavy metal (cadmium) exposure. 60 Furthermore, heavy metals such as Pb are known to induce oxidative stress, 61 oxidative stress modulates DNA methylation during malignant transformation. 62 In addition, trace copper in drinking water has been shown to facilitate formation of Ab plaque in rabbits, 63, 64 although the specific pathway for this effect is not determined. Aluminum has been shown to induce Z-DNA conformation at CCG repeats. 65 Histone acetylation is also likely to function in the LEARn process, with differences in acetylation occurring in response to DNA methylation or demethylation. 66 This, of course, would involve chromatin remodeling. However, it is our contention that changes in DNA oxidation and methylation are the initial means through which LEARn effects arise in reaction to the environment.
Biochemical evidence for the LEARn model
A specific example of LEARn activity may involve the response of Alzheimer-associated genes to early life exposure to the heavy metal lead Pb, although this is not to be taken to mean that Pb is an exclusive operator in the LEARn model. It is presented as a model agent known to influence both DNA methylation 67 and oxidation. 68 When Basha and colleagues introduced Pb acetate into the drinking water of dams of infant rats at 20 days after birth (Pb-E) and into drinking water of age-matched rats at 19 months of age (Pb-L), levels of brain Pb, when all rats were killed at 20 months of age, were the same between early exposed (Pb-E) and control rats but elevated in Pb-L animals. 10 However, at the age of 20 months, the early exposed (Pb-E) rats' APP expression levels and Ab peptide levels increased to levels higher than those of control rats and likewise higher than levels found in Pb-L rats. Longitudinal assays of APP mRNA and Ab peptide levels revealed that these end-of-life changes did not reflect a 'chronic' condition. Although there was a temporary increase in these markers, levels returned to normal levels when Pb was removed from their diet.
When SP1-DNA binding was compared between Pb-E and control rats, this followed a similar trend to APP mRNA levels. SP1-DNA interaction was elevated during initial Pb exposure but fell to normal levels after Pb was removed from the diet. Late in life, SP1-DNA interaction increased significantly above that seen in control animals. In addition, DNA oxidation levels were also measured at end of life, and it was determined that oxo-d8-GTP levels were elevated in Pb-E animals. 10, 68 It was also determined that Pb treatment of cell cultures did not alter enzymatic activity of the a-, b-, or g-secretases that process APP through the amyloidogenic or non-amyloidogenic pathways. However, Pb did increase Ab aggregation in vitro. 69 This in vitro aggregation may have an in vivo counterpart in the discovery that water quality influences Ab aggregation in rabbits, 70 although in that case copper was specifically implicated. 63 Likewise, in humans, elevated concentrations of agrichemicals in surface water in April-July coincided with higher risk of birth defects in live births with last menstrual periods during those months. 71 Cynomolgus monkeys were also exposed to Pb during the first year of life (Pb-E) and were killed for brain tissue analysis at the age of approximate 23 years. Comparing Pb-E brains with control (nonexposed) monkeys revealed that Pb levels between the two groups were the same. On the other hand, APP and SP1 mRNA levels were significantly elevated (BACE1 levels were elevated, but P = 0.06) compared with controls. In addition, Pb-E monkeys had significantly higher levels of Ab42 and Ab40 in later life. Exposed monkeys also showed greater brain amyloid aggregation and more dense aggregates than did nonexposed monkeys. 72 Finally, comparison of DNMT activity in both rodent cells exposed short term to Pb and in the early lifespan Pbexposed monkeys vs. non-exposed cells and animals showed that Pb exposure significantly reduced activity of this enzyme in both systems. 72 It is particularly notable that SP1 is likely to be regulated in a LEARn manner, given that SP1 binds to the human, [73] [74] [75] [76] rhesus monkey, 77 and rat 78 APP promoters and accelerates the production of APP mRNA. 73, 74, 78 Location and frequency of SP1 sites are more similar between monkey and human than between either primate species and rodent. 77 Furthermore, SP1 regulates the expression of the MAPT gene. 79 Notably, SP1 and APP mRNA levels closely follow each other over the life spans of mice and monkeys. 16 
Epidemiological and clinical evidence for the LEARn model
A recent survey of twin pairs for AD with Lewy body dementia showed discordance in 90% of monozygotic twins. 80 In a separate study, a pair of identical twins with discordant development of AD had been brought up in the same household and had similar career paths, both becoming chemical engineers. One twin developed AD, while the other did not. It was determined that DNA methylation levels in the temporal neocortex and the superior frontal gyrus, but not the cerebellum were different from each other, with the AD twin having a lower level of methylation than the non-AD twin. 81 Regarding disorders other than AD, an association between prenatal exposure to Pb and schizophrenia has also been reported. 82, 83 In neurodevelopmental disorders, autism has been associated with DNA hypomethylation in parents. 84 Schizophrenia has been associated with both hypomethylation of MB-COMT 85 and hypermethylation of RELN. 86 Aberrant methylation has been implicated in bipolar disorder. 85, 87 In mood and anxiety disorders, there have been several associations raised with abnormal methylation. 85, 87, 88 Hypermethylation of the gene for ribosomal RNA has been implicated in suicide of individuals who had abusive childhoods. 89 Likewise, epigenetic dysregulation has been observed near several genes involved in neuronal development in the brain in individuals with major psychosis. 90 Although the above clinical data demonstrate association between aberrant methylation states and disease, they do not necessarily show that disease-associated methylation or other epigenetic states have been acquired after prenatal imprinting. Acquisition of an aberrant epigenetic state would be necessary for LEARn-style etiology to apply. It has been recently determined that methylation levels for an individual person change over a period of a decade for 29% of an Icelandic cohort. 91 This raises the possibility of disease-related, environmentally induced methylation states. In addition to lifespan changes in DNA methylation states in humans, delayed neurological response has been demonstrated in rats subjected to postnatal inflammation. The treatment resulted in increased susceptibility to seizure in adulthood. 92 Combination of these various elements, (1) differential methylation patterns in disease; (2) Observed differences of response to early life exposure to Pb may define a more general class of gene regulation in response to methylation and oxidation 'availability'. When Wu et al. 72 performed high-throughput analysis of monkey mRNA with a human neurological microarray, 23 different genes were determined to have altered expression between Pb-exposed and control monkeys. In addition, APP, BACE1 and SP1 mRNA levels were found by northern blot to be elevated in Pbexposed monkeys. Of the 23 microarray-analyzed genes, 6 were upregulated and 17 were downregulated. Three genes' (APP, BACE1, and SP1) mRNA levels were measured by northern blot and found to be elevated in Pb-exposed animals. Sequences of these 26 total genes (Table 1) were downloaded from the human genome project (build 34.3) from À3000 to þ 3000 bp from the þ 1 TSS. An additional 26 'nonresponding' genes were randomly chosen from the same array (Table 1 ) and sequences of À3000/ þ 3000 were downloaded. Sequence groups were compared for cumulative CpG and GG content, in a sliding window of 200 bp. This size of sliding window was chosen as an approximation of the length of DNA in a nucleosome plus linker length between nucleosomes.
When CpG density in this 200 bp window was compared, four regions of significant difference were found (Figure 4a) . Two of these regions were within 500 bp of the þ 1 TSS, whereas two other regions were more distal (near À1000 and À2300). Significant differences in 'GG' doublets, hotspots for DNA oxidation, 93 were found at around À250/À350, þ 250/ þ 350 and near þ 500 (Figure 4b) . The sequence-derived model was tested by comparing it to the sequences of an AD-associated gene that did not show a late life change in expression after Pb exposure, specifically MAPT ( Figure 5 ). Although the MAPT sequence was in agreement with the LEARn model in proximal regions (between À500 and þ 500), it showed differences in CpG density from 'LEARned' genes in a more distal region of interest, specifically around À750/À1000 and around ARGHDIA  ANXA3  PEX5  CALM3  CAPN3  CALR  NF2  HMOX2  CLTC  CETP  PCSK2  NR4A3  DAO  CHRNA1 PEBP1  PLA2G2A  DNM2  CRHR1  PITPNA  SDHA  DRD1  DBH  PLCG2  SP1   a   GDI2  EFNB3  POU4F1  STX7  GNB1  FABP5  PRKACA  HTR1B  GABRA3 RABGGTA  IQGAP1  GABRG2 SCP2  KCNJ4  GDNF  STXBP2  OPRD1  HK1  SYT1  OPRM1  RAB32  RAB5A  RAB5C a Determined by northern blot measurement. Figure 4 Latent Early-life Associated Regulation ('LEARned') vs 'unLEARned' genes, CpG or GG density. Graphs of (a) CpG or (b) GG density of genomic DNA sequences from 26 monkey genes, of À3000 to þ 3000 bases around the þ 1 TSS in 200 bp window. Sequences were chosen after microarray of mRNA or northern blotting of mRNA indicated alterations in expression levels 23 years after exposure to Pb (black line). 72 These were compared to 26 genes with expression levels not altered 23 years after exposure to Pb (gray line). The 'nonresponding' genes were selected at random from the same RNA array that determined the 'responding' genes. Graphs depict standard error of the mean along the sequence of CpG or GG density. Regions where differences in CpG density in the selected window size were significant at P < 0.05 are indicated with brackets under the graphs. LEARn and sporadic disease: a two-hit pathway APP protein, the Ab peptide and t-protein all appear in healthy individuals. Their mere presence is not a sign of active or incipient AD. Therefore, it stands to reason that AD and other idiopathic neurobiological diseases are likely to be 'triggered' independently of the simple presence of any associated proteins. For AD, the LEARn model posits developmental triggering and latency of the APP gene until it is further triggered to express at pathological levels. What could induce APP and Ab peptides to be overproduced in sporadic cases of AD? LEARn proposes that the initial mechanism is primed early in life, at developmental stages. Sites of action for AD would be within the promoter of APP and other AD-associated genes. The trigger would be maintained through epigenetic means, such as DNA methylation. It is also possible that genes with products protective against AD are likely to have altered methylation patterns because of environmental stress. AD, as it usually appears in senescence, would be a 'long-latent' condition, and its etiology would be that of a 'two-hit' disorder, similar to those found in currently accepted models of cancer etiology. 94 In the case of AD, this second hit would be a broad spectrum of changes in gene expression, especially upregulation of inflammatory factors, which has been shown to be a function of normal aging, as has been increased oxidative DNA damage in the aged cortex and specific targeting of genes by such oxidative damage. 95 The possibility of a 'two-hit' etiology for AD has been previously recognized. 96 We extend this concept by proposing a specific gene regulation pathway for this etiology and to encompass neurobiological diseases in general. Environmental insults do not 'intentionally' target AD-related genes in the brain. Instead, certain genes, by juxtaposition of CpG and GG sites with important normally active or inactive transcription factor sites, would be particularly vulnerable to the effects of environmental stresses that alter CpG methylation and G oxidation. Testing such changes could, in part, be carried out by microarray analysis of sporadic and familial AD. If these assays were longitudinal, individual expression profiles could be traced across a lifetime, permitting comparison of the same AD and non-AD individuals at multiple life stages. Such a longitudinal epigenome-wide association study (LE-WAS) would specifically test effects of environment on epigenetic alterations in association with disease.
The LEARn model lies within theories of epigenetics and the epigenome, specifically adapted to the etiology of sporadic disorders of long latency. The epigenome, the collection of epigenetic markers associated with a specific individual organism's genome, 97 has specific epigenotypes, generated by modification of DNA methylation or oxidation, by changes in histone acetylation patterns, and by variations in the physical arrangement of chromosomal material. 98 It is the expression of these epigenotypes, whether they be inherited by imprinting or acquired during life as somatic epitypes, 8 that contributes to development of sporadic neuropsychiatric diseases.
The epigenome is inherently less stable than the genome. The epigenome is subject to changes in epigenetic markers over time within an individual lifespan. For example, when subjects were followed longitudinally over average periods of 11 and 16 years, both increases and decreases in the methylation of an individual person's genome were found in a well-characterized Icelandic sample set and in a cohort of families in Utah. 91 
Further implications of LEARn
The LEARn model proposes environmentally induced changes in DNA methylation and oxidative damage as a fundamental mechanism of pathogenesis in idiopathic sporadic diseases. 7, 68 These perturbations would be latent, not as immediately apparent in the same manner found in conventional toxic responses. Thus, reversal of the symptoms of acute exposure to environmental stressors, such as Pb or poor nutrition, would not necessarily eliminate longlasting repercussions for an environmental insult. Conventional anti-toxicity treatments would be insufficient, because removing the cause would not remove the effect. This could be epidemiologically tested. For example, bans enacted on Pb in gasoline in previous decades significantly reduce levels of Pb in LEARn model of neurobiological disease DK Lahiri et al urban dwellers. However, the LEARn model would suggest that levels of AD would not be likely to decrease in response until 50-60 years after the bans were enacted, when individuals would begin to reach ages at risk of sporadic late onset AD but would not have suffered higher levels of childhood Pb exposure. It should be pointed out that the possibility of 'latent sequelae' to asymptomatic exposure to Pb was raised over 30 years ago, although without a specific underlying mechanism. 99 However, the potential exists that the latent sequelae modeled by LEARn have a longer reach than inducing late life disease in an exposed individual. Several groups have recently raised the possibility that acquired characteristics may very well be heritable. This, possibility, of course, brings to mind the theories of Jean-Baptiste Lamarck, who posited a connection between environmental responses and heritable traits in evolution. 100 An increasing body of evidence has begun to suggest the possibility of medically important heritable traits. 101 Whitelaw and co-workers determined that the epigenetic methylation states of the mouse Axin gene and associated phenotypes were heritable across generations. 102 Anway and Skinner 103 administered the fungicide vinclozolin to mice during gestation and determined that not only did the offspring develop latent disease but the F1-F4 generations of nonexposed offspring developed these same late life disorders at a significant level. Skinner's group further determined that alterations in DNA methylation accompanied the pathogenic changes. 104 The implication of such work is that LEARn pathogenesis operating through altered DNA methylation may permanently instill greater incidence of latent neuropsychiatric disease such as AD in the descendants of an exposed population.
Long-term latency suggests the possibility of biologically based remediation. Changes in methylation and/or oxidative damage to DNA lend toward potential solutions to a LEARn-type environmental exposure. For example, fruit juices, such as concentrated apple juice, have been shown to reverse acute oxidative damage and be a useful source of S-adenosylmethionine, reversing hypomethylation in rats. 105, 106 Treatments based on remediation of oxidative stress should also be explored. It has been determined that low prevalence of AD in an aged African population correlates with absence of oxidative DNA damage. 107 Dietary melatonin supplementation reduced levels of Ab in rat cerebral cortex. 108 This suggests investigation of the use of appropriate dietary supplementation early in life as a prophylactic or treatment measure against possible latent response to environmental insult. In addition, exercise in rats has been shown to modulate the activity of mucosal betaine-homocysteine methyltransferase 2, potentially reducing aberrant methylation. 109 This suggests the possibility that those lifestyle habits suspected to protect against AD, such as physical exercise, 110 may work through remediation of early life aberrant DNA methylation. The LEARn model is not only a useful framework for the study of idiopathic neurobiological disease, but it has further implications in personal and public health practices.
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